96-8785. Advisory Committee on the Medical Uses of Isotopes; Renewal Notice

[Federal Register Volume 61, Number 69 (Tuesday, April 9, 1996)]
[Notices]
[Pages 15838-15839]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-8785]



-----------------------------------------------------------------------


NUCLEAR REGULATORY COMMISSION

Advisory Committee on the Medical Uses of Isotopes; Renewal 
Notice

Agency: U.S. Nuclear Regulatory Commission.

Action: This notice is to announce the renewal of the Advisory 
Committee on the Medical Uses of Isotopes for a period of 2 years.

-----------------------------------------------------------------------

Supplementary Information: The Nuclear Regulatory Commission (NRC) has 
determined that the renewal of the charter for the Advisory Committee 
on the Medical Uses of Isotopes (ACMUI) for the 2 year period beginning 
on April 4, 1996, is in the public interest, in connection with duties 
imposed on the Commission by law. This action is being taken in 
accordance with the Federal Advisory Committee Act, after consultation 
with the Committee Management Secretariat, General Services 
Administration.
    The purpose of the (ACMUI) is to provide advice to the NRC on 
policy and technical issues that arise in regulating the medical use of 
byproduct material for diagnosis and therapy. Responsibilities include 
providing guidance and comments on current and proposed NRC regulations 
and regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use; and evaluating 
training and experience of proposed authorized users. The members are 
involved in preliminary discussions of major issues in determining the 
need for changes in NRC policy and regulation to ensure the continued 
safe use of byproduct material. Each member provides technical 
assistance in his/her specific area(s) of expertise, particularly with 
respect to emerging technologies. Members also provide guidance as to 
NRC's role in relation to the responsibilities of other Federal 
agencies, as well as to professional organizations and boards.
    Members of this Committee have demonstrated professional 
qualifications and expertise in both scientific and non-scientific 
disciplines, including nuclear medicine; nuclear cardiology; radiation 
therapy; medical physics; radiopharmacy; State medical regulation; 
patient's rights and care; health care administration; medical

[[Page 15839]]
research; medical dosimetry, and Food and Drug Administration 
regulation.

For further information please contact: Torre Taylor, Office of Nuclear 
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, MS 
T8F5, Washington, DC 20555; Telephone [phone].

    Dated: April 4, 1996.
Andrew L. Bates,
Federal Advisory Committee Management Officer.
[FR Doc. 96-8785 Filed 4-8-96; 8:45 am]
BILLING CODE 7590-01-P